Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play

Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.